(Alliance News) - Scancell Holdings PLC on Monday reported positive data from an ongoing trial on patients receiving a treatment combination for advanced melanoma, a skin cancer.

The second is set to require 20,000 volunteers, constituting the largest melanoma study ever. The third scheme, funded by ...

Bristol Myers Squibb gets positive CHMP opinion for Opdivo plus Yervoy to treat adult with MSI-H or dMMR metastatic colorectal cancer: Princeton, New Jersey Monday, November 18, 2 ...

TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

Dr Beáta Halassy, a scientist working in a laboratory at the University of Zagreb, experienced a recurrence of breast cancer ...

Researchers have discovered that the Covid-19 virus may hold unexpected benefits for cancer treatment. The virus triggers the ...

The study also showed that the RNA in the COVID-19 virus could incite the production of new immune cells that target and ...

Queen Camilla and her husband King Charles III announced on Nov. 18 that their beloved rescue dog Beth had died.

The gut microbiome, an ecosystem of trillions of microorganisms in the human digestive tract, has been increasingly linked to ...

The most common treatment ... one cutaneous melanoma patient with an ongoing confirmed partial response with -40.2% tumor shrinkage treated at DL7; two patients with ongoing stable diseases with ...

A visionary gift from Pamela Galli AO will sustain and advance research into neurodevelopmental disorders, skin cancer ...